Interestingly, this mechanism is subjected to full use by miR-545 that targets RIG-I and down-regulates its expression to activate PI3K/Akt signaling and promote HCC development (Liu et al., 2016c). The gene discussed is RIGI; the disease is hepatocellular carcinoma.